Hsiu-Mei Chiang1, Hsiang Chang2, Pei-Wun Yao3, Yuh-Shuen Chen4, Kee-Ching Jeng5, Jen-Shu Wang6, Chien-Wei Hou7. 1. Department of Cosmeceutics, China Medical University, Taichung, Taiwan, ROC. 2. Department of Biotechnology, Yuanpei University, Hsinchu, Taiwan, ROC. 3. Institute of Biotechnology, National TsingHua University, Hsinchu, Taiwan, ROC. 4. Department of Food Nutrition, Hungkuang University, Taichung, Taiwan, ROC. 5. Department of Medical Research, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan, ROC. 6. Department of Chinese Medicine, Taichung Tzuchi Hospital, Taichung, Taiwan, ROC. 7. Department of Biotechnology, Yuanpei University, Hsinchu, Taiwan, ROC. Electronic address: rolis.hou@mail.ypu.edu.tw.
Abstract
BACKGROUND: In this study, we investigated the potential anti-inflammatory and antioxidative effects of sesamin on acute liver injury. Lead (Pb) causes oxidative damage and enhances the effects of low-dose lipopolysaccharide (LPS), inducing acute hepatic injury in rats. METHODS: Male Sprague-Dawley rats were given intraperitoneal injections of Pb acetate (5 mg/kg) and LPS (50 μg/kg) to induce liver injury, and we tested the effects of oral administration of sesamin (10 mg/kg) on liver damage. To assess the extent of acute hepatic injury in the rats, we measured the anti-inflammatory and antioxidant markers and relevant signaling pathways: serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), C-reactive protein (CRP), reactive oxygen species (ROS), tumor necrosis factor (TNF)-α, interleukin (IL)-1, IL-6, nitric oxide (NO), and cyclooxygenase-2 (COX-2), inducible NO synthase (iNOS) levels, mitogen-activated protein kinases (MAPKs), c-Fos, and GADD45β. RESULTS: Sesamin significantly decreased the serum AST, ALT, and CRP levels in the rat model. In the Pb and LPS-stressed rats, sesamin administration reduced the serum levels of TNF-α, IL-1, IL-6, NO, and ROS generation, and liver tissue expressions of c-Jun N-terminal kinase (JNK), p38 MAPK, GADD45β, COX-2, and iNOS. CONCLUSION: Collectively, these results demonstrate that sesamin is associated with antioxidant and anti-inflammatory activity. The observed effect of scavenging of ROS and NO and inhibiting the production of proinflammatory cytokines may be achieved through the suppression of COX-2, iNOS, and MAPK pathways in the acute hepatic injury rats.
BACKGROUND: In this study, we investigated the potential anti-inflammatory and antioxidative effects of sesamin on acute liver injury. Lead (Pb) causes oxidative damage and enhances the effects of low-dose lipopolysaccharide (LPS), inducing acute hepatic injury in rats. METHODS: Male Sprague-Dawley rats were given intraperitoneal injections of Pb acetate (5 mg/kg) and LPS (50 μg/kg) to induce liver injury, and we tested the effects of oral administration of sesamin (10 mg/kg) on liver damage. To assess the extent of acute hepatic injury in the rats, we measured the anti-inflammatory and antioxidant markers and relevant signaling pathways: serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), C-reactive protein (CRP), reactive oxygen species (ROS), tumor necrosis factor (TNF)-α, interleukin (IL)-1, IL-6, nitric oxide (NO), and cyclooxygenase-2 (COX-2), inducible NO synthase (iNOS) levels, mitogen-activated protein kinases (MAPKs), c-Fos, and GADD45β. RESULTS:Sesamin significantly decreased the serum AST, ALT, and CRP levels in the rat model. In the Pb and LPS-stressed rats, sesamin administration reduced the serum levels of TNF-α, IL-1, IL-6, NO, and ROS generation, and liver tissue expressions of c-Jun N-terminal kinase (JNK), p38 MAPK, GADD45β, COX-2, and iNOS. CONCLUSION: Collectively, these results demonstrate that sesamin is associated with antioxidant and anti-inflammatory activity. The observed effect of scavenging of ROS and NO and inhibiting the production of proinflammatory cytokines may be achieved through the suppression of COX-2, iNOS, and MAPK pathways in the acute hepatic injuryrats.
Authors: Md Sohel; Md Nurul Islam; Md Arju Hossain; Tayeba Sultana; Amit Dutta; Md Sohanur Rahman; Suraiya Aktar; Khairul Islam; Abdullah Al Mamun Journal: Int J Breast Cancer Date: 2022-02-17